Literature DB >> 20004539

Prescribing postmenopausal hormone therapy to women in their 50s in the post-Women's Health Initiative era.

Jacques E Rossouw.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 20004539      PMCID： PMC2827040          DOI： 10.1016/j.maturitas.2009.11.012

Source DB:  PubMed          Journal:  Maturitas        ISSN： 0378-5122            Impact factor:   4.342


× No keyword cloud information.
  6 in total

1.  Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

Authors:  Jacques E Rossouw; Ross L Prentice; JoAnn E Manson; Lieling Wu; David Barad; Vanessa M Barnabei; Marcia Ko; Andrea Z LaCroix; Karen L Margolis; Marcia L Stefanick
Journal:  JAMA       Date:  2007-04-04       Impact factor: 56.272

2.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

3.  Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.

Authors:  Garnet L Anderson; Marian Limacher; Annlouise R Assaf; Tamsen Bassford; Shirley A A Beresford; Henry Black; Denise Bonds; Robert Brunner; Robert Brzyski; Bette Caan; Rowan Chlebowski; David Curb; Margery Gass; Jennifer Hays; Gerardo Heiss; Susan Hendrix; Barbara V Howard; Judith Hsia; Allan Hubbell; Rebecca Jackson; Karen C Johnson; Howard Judd; Jane Morley Kotchen; Lewis Kuller; Andrea Z LaCroix; Dorothy Lane; Robert D Langer; Norman Lasser; Cora E Lewis; JoAnn Manson; Karen Margolis; Judith Ockene; Mary Jo O'Sullivan; Lawrence Phillips; Ross L Prentice; Cheryl Ritenbaugh; John Robbins; Jacques E Rossouw; Gloria Sarto; Marcia L Stefanick; Linda Van Horn; Jean Wactawski-Wende; Robert Wallace; Sylvia Wassertheil-Smoller
Journal:  JAMA       Date:  2004-04-14       Impact factor: 56.272

4.  Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease.

Authors:  Miguel A Hernán; Alvaro Alonso; Roger Logan; Francine Grodstein; Karin B Michels; Walter C Willett; Joann E Manson; James M Robins
Journal:  Epidemiology       Date:  2008-11       Impact factor: 4.822

5.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

6.  Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.

Authors:  Ross L Prentice; Joann E Manson; Robert D Langer; Garnet L Anderson; Mary Pettinger; Rebecca D Jackson; Karen C Johnson; Lewis H Kuller; Dorothy S Lane; Jean Wactawski-Wende; Robert Brzyski; Matthew Allison; Judith Ockene; Gloria Sarto; Jacques E Rossouw
Journal:  Am J Epidemiol       Date:  2009-05-25       Impact factor: 4.897
  6 in total
  2 in total

1.  Letter to the editor.

Authors:  Robert Brunner
Journal:  Menopause       Date:  2010-10-20       Impact factor: 2.953

Review 2.  Targeting the non-classical estrogen pathway in neurodegenerative diseases and brain injury disorders.

Authors:  Zsombor Koszegi; Rachel Y Cheong
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-15       Impact factor: 6.055
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.